Shepard v. Byrd

581 F. Supp. 1374, 1984 U.S. Dist. LEXIS 19563
CourtDistrict Court, N.D. Georgia
DecidedFebruary 10, 1984
DocketCiv. A. C81-194R
StatusPublished
Cited by5 cases

This text of 581 F. Supp. 1374 (Shepard v. Byrd) is published on Counsel Stack Legal Research, covering District Court, N.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Shepard v. Byrd, 581 F. Supp. 1374, 1984 U.S. Dist. LEXIS 19563 (N.D. Ga. 1984).

Opinion

ORDER

HAROLD L. MURPHY, District Judge.

The plaintiff in this action has brought both section 1983 and pendent malicious-prosecution claims against the defendants. Presently before the Court are motions to dismiss filed by (1) Van Morrison and the Enloe Drug Company; (2) Ron Byrd and Ron Bieri; and (3) the Georgia State Board of Pharmacy and its members — Eugene Argo, Neil Pruitt, Clara Axam, Oren Harden, Peter Mills and Martin Grizzard. These motions concern both the section 1983 and pendent malicious-prosecution claims brought against the defendants. The motions were brought under Fed.R.Civ.P. 12(b)(6), but will be treated as motions for summary judgment 1 (and referred to as *1380 such) because matters outside the pleadings have been presented to and considered by this Court. See id. 12(b); see generally Finn v. Gunter, 722 F.2d 711 (11th Cir. 1983).

The Court grants the Enloe Drug Company’s motion for summary judgment on the section 1983 claim because the alleged constitutional deprivations the plaintiff suffered were not inflicted pursuant to a policy or custom adopted by Enloe. The motion for summary judgment on the section 1983 claim filed by the State Board of Pharmacy and its members is granted because they are immune from suit. The pendent claims brought against the Enloe Drug Company, the Board and its members are also dismissed. The summary judgment motion filed by Byrd and Bieri concerning the section 1983 claim is granted, but it is denied as it applies to the pendent malicious-prosecution claim. The motion for summary judgment filed by Morrison is denied as to both claims because of his substantial involvement in the arrest of Cliff Shepard. The facts, construed most favorably in the plaintiff’s favor, are as follows.

I. FACTS

Cliff Shepard, the plaintiff, 2 was a licensed pharmacist in the State of Georgia. He owned and operated the Garden Lakes Pharmacy in Rome, Georgia from 1972 until 1978. His health forced him to sell the Garden Lakes Pharmacy in November 1978 to Bud Landers. His health also had led him to hire several pharmacists to aid him in operating the pharmacy before he sold it in November 1978. See Deposition of Shepard at 20.

In January 1979 an accountability audit of some of the Schedule II (controlled substance) drugs at the Garden Lakes Pharmacy was performed by Ron Byrd, an agent of the Georgia Drug and Narcotics Agency (“GDNA”). 3 These audits are routinely performed when a change-of-ownership occurs at a pharmacy. The audit revealed substantial shortages of Schedule II drugs. 4 Shepard was not notified about these shortages. See id. at 48.

On March 19, 1979 Shepard was employed by the Enloe Drug Company (“Enloe”) at one of its stores in Rome, Georgia, which will be referred to as “Store No. 7.” Van Enloe III owned Store No. 7 and Dwight Morrison was the chief pharmacist there. Shepard and Morrison were the only full-time pharmacists at Store No. 7, although two pharmacists were employed on a part-time basis. See id. at 25. Morrison and Shepard worked on an alternating-shift basis. See Tr. at 5. 5 Morrison performed all inventories of drugs at Store No. 7 and ordered all Schedule II drugs for the store. See Affidavit of Morrison at 1-2; Deposition of Shepard at 43. Only Morrison, Shepard and Enloe had keys to the safe in which controlled substances were kept. Morrison felt some personal animosity towards Shepard and felt threatened in his position as chief pharmacist. See id. at 43, 49-50, 53, 74.

*1381 Morrison inventoried the Schedule II drugs at Store No. 7 on May 1, 1979. Sometime after this inventory, Morrison noticed a shortage of Schedule II drugs, especially percodan tablets. He notified Van Enloe III about this shortage, who contacted the GDNA. Two GDNA agents — Ron Byrd and Ron Bieri — were assigned to investigate the situation.

Byrd and Bieri set-up an undercover operation. They first persuaded Dr. Gene Davidson to provide them with four false prescriptions for percodan tablets. On June 19, 1979 they inventoried the percodan tablets at Store No. 7, and Morrison assisted them with this inventory. Morrison also showed Byrd and Bieri a prescription for 60 percodan tablets which apparently was brought forward from a past inventory period to the present one and which was logged-in during one of Shepard’s shifts. On June 20, 1979 Bieri, acting as a customer named Chris Berry, presented one of the false prescriptions to Shepard. The prescription was for 12 percodan tablets, and Shepard correctly filled it. That night Byrd and Bieri inventoried the percodan tablets at Store No. 7, again with the assistance of Morrison. They noticed that the prescription Bieri had given Shepard was altered to show that 42 percodan tablets had been dispensed. Byrd and Bieri also found that 34 percodan tablets were missing.

Byrd and Bieri staked-out Store No. 7 from 9:00 p.m. until 5:00 a.m. on the night of June 21, 1979, expecting Shepard to visit Store No. 7 after closing. See Tr. at 56. Shepard did not visit the Store. Several days later, Byrd contacted Van Enloe III and asked him to arrange to have Shepard work at Store No. 7 on June 26, 1979. Enloe did so. Byrd also obtained an arrest warrant for Shepard based on the June 20, 1979 incident, after consulting with the assistant district attorney for Floyd County.

On the night of June 25, 1979 Morrison, Byrd and Bieri again took an inventory of the percodan tablets at Store No. 7. After taking this inventory, Byrd and Bieri apparently took Morrison’s key to the safe in which the controlled substances were kept. On June 26, 1979 Bieri again presented Shepard with a false prescription for 12 percodan tablets, and Shepard correctly filled it. Shepard was arrested as he exited Store No. 7 at about 10:00 p.m. that night. When he was arrested, Shepard had a bottle of 72 percodan tablets in the pocket of the smock he was wearing.

After Shepard’s arrest, Byrd and Bieri conducted another inventory of the percodan tablets at Store No. 7. Ten percodan tablets were missing and the prescription Bieri had presented to Shepard for 12 percodan tablets on June 26, 1979 was altered to show that 42 percodan tablets had been dispensed. Also, a percodan prescription for a person named Linda Shores had apparently been altered from an unintelligible number — possibly the number 18 — to 40.

Shepard was indicted on five counts of obtaining percodan tablets by fraud on September 12, 1979. See Byrd and Bieri’s Motion for Summary Judgment, Exhibit A. On July 10, 1979 the State Board of Pharmacy (the “Board”) suspended Shepard’s license to practice pharmacy pending an evidentiary hearing. A notice of the hearing, which set forth the charges levelled against Shepard and .outlined his rights at the hearing, accompanied the notice of suspension. See

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Samuel v. Michaud
980 F. Supp. 1381 (D. Idaho, 1996)
Penaranda v. Cato
740 F. Supp. 1578 (S.D. Georgia, 1990)
Garmon v. Lumpkin County
878 F.2d 1406 (Eleventh Circuit, 1989)
Rojas v. Alexander's Department Store, Inc.
654 F. Supp. 856 (E.D. New York, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
581 F. Supp. 1374, 1984 U.S. Dist. LEXIS 19563, Counsel Stack Legal Research, https://law.counselstack.com/opinion/shepard-v-byrd-gand-1984.